Watch: AquaInSilico CEO Jorge Santos on how Upwater could transform wastewater treatment
AquaInSilico co-founder and ceo Jorge Santos talks about the launch of Upwater, the company’s first commercial platform, and future scale up plans.
Read moreAquaInSilico launches first commercial services to reduce environmental impact of wastewater treatment
AquaInSilico has launched its first commercial services to help industry and government significantly reduce the environmental impact of their wastewater treatment plants.
Read moreWatch: Dekiln is scaling up says chief executive Dr Aled Roberts
Dekiln is to start scale up of its sustainable alternatives to ceramic tiles with plans to invest in an
Read moreWatch: Frontier IP CEO Neil Crabb discusses how the innovation hub will help to accelerate growth
Frontier IP’s innovation hub, to be developed in partnership with Abstract Securities, will help to support portfolio and other start-up and early stage companies. Neil explains more in this video.
Read moreFrontier IP to open innovation hub in Cambridge
Frontier IP has entered into a strategic partnership with Abstract Mid-Tech Limited (“Abstract”), an associate company of Abstract Securities Limited, a specialist in commercial property development, investment and venture capital financing, to create a new innovation hub in Cambridge.
Read moreWatch: Alusid CEO on the company’s European expansion
Alasdair Bremner discusses Alusid’s distribution deal with 3D Wall Panels Italia. It is the Company’s second international agreement, following the deal with Dutch sustainable materials specialist FRONT Materials. It is a further milestone achieved as Alusid explores options for an IPO.
Read moreAlusid expands in Europe with Italian distribution agreement
Alusid has signed a distribution agreement with 3D Wall Panels Italia, a leading supplier based in Milan whose clients include Primark, Zara, Lavazza and Club Med. It follows the deal with Dutch distributor FRONT Materials BV signed earlier this year.
Read moreThe Vaccine Group’s African Swine Fever vaccine enters animal trials
African Swine Fever is a highly contagious and devasting disease prevalent worldwide. There is currently no safe and effective vaccine. A vaccine candidate developed The Vaccine Group in collaboration with The Pirbright Institute has now entered animal trials.
Read moreWatch: TVG CEO Jeremy Salt on Syva collaboration and what’s next for the company
The Vaccine Group has entered a collaboration with global animal health group Syva to develop a vaccine against zoonotic pig disease Streptococcus suis. CEO Jeremy Salt discusses the partnership, other vaccine developments and the company’s work on biotherapeutics.
Read moreAnimal health group Syva to collaborate with The Vaccine Group
The Vaccine Group has entered into a collaboration with leading Spanish animal health group Syva to develop a vaccine against Streptococcus suis, an economically damaging and zoonotic pig disease.
Read more